реферат скачать
 
Главная | Карта сайта
реферат скачать
РАЗДЕЛЫ

реферат скачать
ПАРТНЕРЫ

реферат скачать
АЛФАВИТ
... А Б В Г Д Е Ж З И К Л М Н О П Р С Т У Ф Х Ц Ч Ш Щ Э Ю Я

реферат скачать
ПОИСК
Введите фамилию автора:


Механизмы устойчивости опухолей к цисплатину

20. Gill JS, Mindebank AJ. Cisplatin-induced apoptosis in rat dorsal

root ganglion neurons is associated with attempted entry into the

cell cycle. J Clin Invest 1998, 101(12): 2842-50.

21. Megyesi J, Safirstein RL, Price PM. Induction of p 21

WAF1?CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-

induced acute renal failure. J Clin Invest 1998, 101(4): 777-82.

22. Otto AM, Paddenberg R, Schubert S, Mannherz HG. Cell cycle

arrest, micronucleus formation, and cell death in growth inhibition

of MCF-7 breast cancer cells by tamoxifen and cisplatin. J Cancer Res

Clin Oncol 1996, 122(10): 603-612.

23. Boersma AW, Nooter K, Oostrum RG, Stoter G. Quantification of

apoptotic cells with fluorescein isothiocyanate-labeled annexin V in

chinese hamster ovary cells cultures treated with cisplatin.

Cytometry 1996, 24(2): 123-130.

24. Ormerod MG, O`Neill C, Robertson D, Helland LR, Harrap KR. Cis-

diamminedichloroplatinum (II)-induced cell death through apoptosis in

sensitive and resistant human ovarian carcinoma cell lines. Cancer

Chemother Pharmacol 1996, 37(5): 463-471.

25. Uslu R, Jewett A, Bonavida B. Sensitization of human ovarian

tumor cells by subtoxic CDDP to anti-fas antibody mediated

cytotoxicity and apoptosis. Gynecol Oncol 1996, 62(2): 282-91.

26. Fulda S, Sieverts H, Friesen C, Herr I, Debatin KM. The CD95(APO-

1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells.

Cancer Res 1997, 57(17): 3823-9.

27. McGahon AJ, Costa Pereira AP, Daly L, Cotter TG. Chemotherapeutic

drug-induced apoptosis in human leukaemic cells is independent of the

Fas(APO-1/CD95) receptor/ligand system. Br J Haematol 1998, 101(3):

539-47.

28. Antoku K, Liu Z, Johnson DE. Inhibition of caspase proteases by

CrmA enhances the resistance of human leukemia cells to multiple

chemotherapeutic agents. Leukemia 1997, 11(10): 1665-72.

29. Chen Z, Naito M, Mashima T, Tsuruo T. Activation of actin-

cleavable interleukin 1 beta-converting enzyme (ICE) family protease

CPP-32 during chemotherapeutic agent-induced apoptosis in ovarian

carcinoma cells. Cancer Res 1996, 56(22): 5224-9.

30. Marissen WE, Lloyd RE. Eukariotic translation initiation factor

4G is targeted for proteolytic cleavage by caspase 3 during

inhibition of translation in apoptotic cells. Mol Cell Biol 1998,

18(12): 7565-74.

31. Kraker AJ, Moore CW. Accumulation of cis-diamminedichloroplatinum

(II) and platinum analogues by platinum-resistant murine leukemia

cells in vitro. Cancer Res 1988; 48: 9-13.

32. Eichholtz-Wirth H, Hietel B. The relationship between cisplatin

sensitivity and drug uptake into mammalian cells in vitro. Br J

Cancer 1986; 54: 239-43.

33. Kawai K, Kamatani N, Georges E, Ling V. Identification of a

membrane glycoprotein overexpression in murine lymphoma sublines

resistant to cis- diamminedichloroplatinum (II). J Biol Chem 1990;

265: 13137-42.

34. Ishikawa T, Wright CD, Ishizuka H. GS-X pump Is functionally

overexpressed in cis-diamminedichloroplatinum (II)-resistant human

leukemia HL-60 Cells and downregulated by cell differentiation. J

Biol Chem 1994; 269: 29085-93.

35. Goto S, Yoshido K, MoriKawa T, Urata Y, Suzuki K,. Kondo T.

Augmentation of transport for cisplatin-glutathione adduct in

cisplatin-resistant cancer cells. Cancer Res 1995; 55: 4297-301.

36. Veneroni S, Zaffaroni N, Daidone MG, Benini E, Villa R,

Silvestrini R. Expression of P-glycoprotein and in vitro or in vivo

resistance to doxorubicin and cisplatin in breast and ovarian

cancers. Eur J Cancer 1994; 30A: 1002-7.

37. Jedlitschky G, Leier J, Buchholz U, Barnouin K, Kurz G, Keppler

D. Transport of glutathione, glucuronate, and sulfate conjugates by

the MRP gene-encoded conjugate export pump. Cancer Res 1996; 56: 988-

94.

38. Okuyama T, Maehara Y, Endo K, Baba H, Adachi Y, Kuwano M,

Sugimachi K. Expression of glutathione S-transferase-pi and

sensitivity of human gastric cancer cells to cisplatin. Cancer 1994;

74: 1230-6.

39. Awasthi S, Sharma R, Singhal SS, Herzog NK, Chaubey M, Awasthi

YC. Modulation of cisplatin cytotoxicity by sulphasalazine. Br J

Cancer 1994; 70: 190-4.

40. Bongers V, Snow GB, Braakhuis BJM. The role of glutathione S-

transferases in head and neck squamous cell carcinogenesis. Eur J

Cancer 1995; 31B: 349-54.

41 Minagawa Y, Kigawa J, Ishihara H, Itamochi H, Terakawa N.

Synergistic enhancement of cisplatin cytotoxicity by SN-38, an active

metabolite of CPT-11, for cisplatin-resistant HeLa cells. Jpn J

Cancer Res 1994; 85: 966-71.

42. Boscia RE, Korbut T, Holden SA, Ara G, Teicher BA. Interaction of

topoisomerase I inhibitors with radiation in cis-

Diamminedichloroplatinum (II)-sensitive and -resistant cells in vitro

and in the FSAIIC fibrosarcoma in vivo. Int J Cancer 1993; 53: 118-

23.

43. Kikuchi Y, Hirata J, Yamamoto K, Ishi K, Kita T, Kudoh K, Tode

T, Nagata I, Taniguchi K, Kuwano M. Altered expression of ?-

glutamylcysteine synthetase, metallothionein and topoisomerase I or

II during acquisition of drug resistance to cisplatin in human

ovarian cancer cells. Jpn J Cancer Res 1997; 88: 213-7.

44. Hirata J, Kikuchi Y, Kita T, Imaizumi EE, Tode T, Ishii K, Kudoh

K, Nagata I. Modulation of sensitivity of human ovarian cancer cells

to cis-diamminedichloroplatinum (II) by 12-O-tetradecanoylphorbol-13-

acetate and D,L-Buthionine-S,R-Sulphoximine. Int J Cancer 1993; 55:

521-7.

45.Sugimoto C, Matsukawa S, Fujieda S, Noda I, Tanaka N, Tsuzuki H,

Saito H. Involvement of intracellular glutathione in induction of

apoptosis by cisplatin in a human pharyngeal carcinoma cell line.

Anticancer Res 1996; 16: 675-80.

46. Pendyala L, Perez R, Weinstein A, Zdanowicz J, Creaven PJ. Effect

of glutathione depletion on the cytotoxicity of cisplatin and

iproplatin in a human melanoma cell line. Cancer Chemother Pharmacol

1997, 40 (1): 38-44.

47. Kurokawa H, Nishio K, Ishida T, Arioka H, Fukuoka K, Nomoto T,

Fukumoto H, Yokote H, Saijo N. Effect of glutathione depletion on

cisplatin resistance in cancer cells transfected with the ?

-glutamylcysteine synthetase gene. Jpn J Cancer Res 1997; 88: 108-

10.

48. Campling BG, Baer K, Baker HM, Lam YM. Cole SPC. Do glutathione

and related enzymes play a role in drug resistance in small cell lung

cancer ctll lines? Br J Cancer 1993; 68: 327-35.

49. Kodera Y, Akiyama S, Isobe K, Kondo K, Ito K, Yamauchi M, Takagi

H. Expression of ?-glutathione S-transferase gene (GSTP1) in gastric

cancer: lack of correlation with resistance against cis-

diamminedichloroplatinum (II). Eur J Cancer 1994; 30A: 2158-62.

50. Mellish KJ, Kelland LR, Harrap KR. In vitro platinum drug

chemosensitivity of human cervical squamous cell carcinoma cell lines

with intrinsic and acquired resistance to cisplatin. Br J Cancer

1993; 68: 240-50.

51. Eichholtz-Wirth H, Reidel G, Hietel B. Radiation-induced

transient cisplatin resistance in murine fibrosarcoma cells

associated with elevated metallothionein content. Br J Cancer 1993;

67: 1001-6.

52. Lazo JS, Basu A. Metallothionein expression and transient

resistance to electrophilic antineoplastic drugs. Semin Cancer Biol

1991; 2: 267-71.

53. Hishikawa Y, Abe SI, Kinugasa S, Yoshimura H, Monden N.

Overexpression of metallothionein correlates with chemoresistance to

cisplatin and prognosis in esophageal cancer. Oncology 1997; 54: 342-

7.

54. Vaisman A, Vachenko M, Said I, Chaney SG. Cell cycle changes

associated with formation of Pt-DNA adducts in human ovarian

carcinoma cells with different cisplatin sensitivity. Cytometry 1997;

27: 54-64.

55. Hill BT, Scanlon KJ, Hansson J, Harstrick A, Pera M,

Fichtinger-Schepman AMJ, Shellard SA. Deficient repair of cisplatin-

DNA adducts identified in human testicular teratoma cell lines

established from tumours from untreated patients. Eur J Cancer 1994;

30A: 832-7.

56. Johnson SW, Swiggard PA, Handel LM, Godwin AK, Ozols RF, Hamilton

TC. Relationship between platinum-DNA adduct formation and removal

and cisplatin cytotoxicity in cisplatin-sensitive and resistant human

ovarian cancer cells. Cancer Res 1994, 54: 5911-6.

57. Turchi JJ, Li M, Henkels KM. Cisplatin-DNA binding specificity

of calf high mobility group I protein. Biochem 1996; 35: 2992-3000.

58.Ikeda S, Ozaki K. Action of mitochondrial endonuclease G on DNA

damaged by L-ascorbic acid, peplomycin, and cis-

diamminedichloroplatinum (II). Biochem Biophys Res Commun 1997,

235(2): 291-4.

59. Bissett D, McLaughlin K, Kelland LR, Brown R. Cisplatin-DNA

damage recognition proteins in human tumor extracts. Br J Cancer

1993; 67:742-8.

60. McLaughlin K, Coren G, Masters J, Brown R. Binding activities of

cis-platin-damage-recognition proteins in human tumor cell lines. Int

J Cancer 1993; 53: 662-6.

61. Brown R, Hirst GL, Gallagher WM, McIlwrath AJ, Margison GP, Zee

AG, Anthoney DA. HMLN1 expression and cellular responses of ovarian

tumor cells to treatment with cytotoxic anticancer agents. Oncogene

1997, 15(1): 45-52.

62. Lanzi C, Perego P, Supino R, Romanelli S, Pensa T, Carenini N,

Viano I, Colangelo D, Leone R, Apostoli P, Cassinelli G, Gambetta RA,

Zunino F. Decreased drug accumulation and increased tolerance to DNA

damage in tumor cells with a low level of cisplatin resistance.

Biochem Pharmacol 1998, 55(8): 1247-54.

63. Fishel R, Ewel A, Lescoe MC. Purified human MSH2 protein binds to

DNA containing mismatched nucleotides. Cancer Res 1994; 54: 5539-42.

64. Loeb LA. Microsatellite instability: marker of a mutator

phenotype in cancer. Cancer Res 1994; 54: 5059-63.

65. Chu G. Cellular responces to Cisplatin. J Biol Chem 1994; 269:

787-90.

66. Sorenson CM, Eastman A. Influence of cis-Diamminedichloroplatinum

(II) on DNA synthesis and cell cycle progression in excision repair

proficient and deficient hamster ovary cells. Cancer Res 1988; 48:

6703-7.

67. Li Q, Gardner K, Zhang L, Tsang B, Bostick-Bruton F, Reed E.

Cisplatin induction of ERCC-1 mRNA expression in A2780/CP70 human

ovarian cancer cells. J Biol Chem 1998, 273 (36): 23419-25.

68. Husain A, He G, Venkatraman ES, Spriggs DR. BRCA1 up-regulation

is associated with repair-mediated resistance to cis-

diamminedichloroplatinum (II). Cancer Res 1998, 58 (6): 1120-3.

69. Mestdach N, Pommery N, Saucier JM, Hecquet B, Founier C,

Slomianny C, Teissier E, Henichart JP. Chemoresistance to doxorubicin

and cisplatin in a murine cell line. Analysis of P-Glycoprotein,

topoisomerase II activity, glutathione and related enzymes.

Anticancer Res 1994; 14: 869-74.

70. Kondo H, Kanzawa F, Nishio K, Saito S, Saijo N. In vitro and

in vivo effects of cisplatin and etoposide in combination on small

cell lung cancer cell lines. Jpn J Cancer Res 1994; 85: 1050-6.

71. Jong S, Timmer-Bosscha H, Vries EGE, Mulder NH. Effect of

novobiocin on cisplatin cytotoxicity and DNA interstrand cross-link

formation in a cisplatin-resistant, small-cell lung carcinoma cell

line. Int J Cancer 1993; 53: 110-7.

72. Guchelaar H-J, Timmer-Bosscha H, Dam-Meiring A, Uges DRA,

Oosterhuis JW, Vries EGE Mulder NH. Enhancement of cisplatin and

etoposide cytotoxicity after all-trans retinoic-acid-induced cellular

differentiation of a murine embryonal carcinoma cell line. Int J

Cancer 1993; 55: 442-7.

73. Seki S, Hongo A, Zhang B, Akiyama K, Sarker AH, Kudo T.

Inhibition of cisplatin-mediated DNA damage in vitro by

ribonucleotides. Jpn J Cancer Res 1993; 84: 462-7.

74. Parekh HK, Simpkins H. The differential expression of

citokeratin 18 in cisplatin-sensitive and -resistant human ovarian

adenocarcinoma cells and its association with drug sensitivity.

Cancer Res 1995; 55: 5203-6.

75. Mirakhur B, Parekh HK, Simpkins H. Expression of the cisplatin

resistance phenotype in a human ovarian carcinoma cell line

segregates with chromosomes 11 and 16. Cancer Res 1996; 56: 2256-

62.

76. Mueller H, Eppeberger U. The dual role of mutant p 53 protein in

chemosensitivity of human cancers. Anticancer Res 1996, 16 (6B): 3845-

8.

77. Kawasaki t, Tomita Y, Bilim V, Takeda M, Takahashi K, Kumanishi

T. Abrogation of apoptosis induced by DNA-damaging agents in human

bladder-cancer cell lines with p 21/WAF1/CIP1 and/or p 53 gene

alterations. Int J Cancer 1996, 68 (4): 501-5.

78. Kondo S, Barna BP, Kondo Y, Tanaka Y, Casey G, Liu J, Morimura T,

Kaakaji R, Peterson JW, Werbel B, Barnett GH. WAF1/CIP1 increases the

susceptibility of p 53 non-functional malignant glioma cells to

cisplatin-induced apoptosis. Oncogene 1996, 13 (6): 1279-85.

79. Li G, Tang L, Zhou X, Tron V, Ho V. Chemotherapy-induced

apoptosis in melanoma cells is p 53 dependent. Melanoma Res 1998, 8

(1): 17-23.

80. Biagosklonny MV, El-Deiry WS. Acute overexpression of wt p 53

facilitates anticancer drug-induced death of cancer and normal cells.

Int J Cancer 1998, 75 (6): 933-940.

81. Li R, Sutphin PD, Schwartz D, Matas D, Almog N, Wolkowicz R,

Goldginger N, Pei H, Prokocimer M, Rotter V. Mutant p 53 protein

interferes with p 53-independent apoptotic pathways. Oncogene 1998,

16 (25): 3269-77.

82. Vasey PA, Jones NA, Jenkins S, Dive C, Broun R. Cisplatin,

camptothecin, and taxol sensitivities of cells with p 53-associated

multidrug resistance. Mol Pharmacol 1996, 50 (6): 1536-40.

83. Vikhanskaya F, Clerico L, Valenti M, Stazione NS, Broggini M,

Parodi S, Russo P. Mechanism of resistance to cisplatin in a human

ovarian-carcinoma cell line selected for resistance to doxorubicin:

possible role of p 53. Int J Cancer 1997, 72 (1): 155-9.

84. Vaisman A, Varchenko M, Said I, Chaney SG. Cell cycle changes

associated with formation of Pt-DNA adducts in human ovarian

carcinoma cells with different cisplatin sensitivity. Cytometry 1997,

27 (1): 54-64.

85. Siddik ZH, Mims B, Lozano G, Thai G. Independent pathways of p 53

induction by cisplatin and X-rays in a cisplatin-resistant ovarian

tumor cell line. Cancer Res 1998, 58 (4): 698-703.

86. Ju JF, Banerjee D, Lenz HJ, Danenberg KD, Schmittgen TC, Spreas

CP, Schonthal AH, Manno DJ, Hochhauser D, Bertino JR, Danenberg PV.

Restoration of wild-type p 53 activity in p 53-null HL-60 cells

confers multidrug sensitivity. Clin Cancer Res 1998, 4 (5): 1315-22.

87. Fajac A, Da Silva J, Ahomadegbe JC, Rateau JG, Bernaudin JF, Riou

G, Benard J. Cisplatin-induced apoptosis and p 53 gene status in a

cisplatin-resistant human ovarian carcinoma cell line. Int J Cancer

1996, 86 (1): 67-74.

88. Kondo S, Barna BP, Morimura T, Takeuchi J, Yuan J, Akbasak A,

Barnett GH. Interleukin-1-beta-converting enzyme mediates cisplatin-

induced apoptosis in malignant glioma cells. Cancer Res 1995, 55

(24): 6166-71.

89. De Feudis P, Debernardis D, Beccaglia P, Valenti M, Sire GE,

Arzani D, Stanzione S, Parodi S, D`Incalci M, Russo P, Broggini M.

DDP-induced cytotoxicity is not influenced by p 53 in nine human

ovarian cancer cell lines with different p 53 status. Br J Cancer

1997, 76 (4): 474-9.

90. Burger H, Nooter K, Boersma AW, Kortland CJ, Stoter G. Expression

of p 53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular

germ cell tumor cell lines. Br J Cancer 1998, 77 (10): 1562-7.

91. Ikeguchi M, Tatebe S, Kaibara N, Ito H. Changes in levels of

expression of p 53 and the product of the bcl-2 in lines of gastric

cancer cells during cisplatin-induced apoptosis. Eur Surg Res 1997,

29 (5), 396-402.

92. Pestell KE, Medlow CJ, Titley JC, Kelland LR, Walton MI.

Characterisation of the p 53 status, BCL-2 expression and radiation

and platinum drug sensitivity of a panel of human ovarian cancer cell

lines. Int J Cancer 1998, 77 (6): 913-8.

93. Nakata B, Chung KH, Ogawa M, Yanagawa K, Muguruma K, Inoue T,

Yamashita Y, Onoda N, Maeda K, Sawada T, Sowa. P 53 protein

overexpression as a predictor of the response to themotherapy in

gastric cancer. Surg Today 1998, 28 (6): 595-8.

94. Petty R, Evans A, Duncan I, Kurbacher C, Cree I. Drug resistance

in ovarian cancer – the role of p 53. Payhol Oncol Res 1998, 4 (2):

97-102.

95. Simonian PL, Grillot DA, Andrews DW, Leber B, Nunez G. Bax

homodimerization is not required for Bax to accelarate chemotherapy-

induced cell death. J Biol Chem 1996, 271 (50): 32073-7.

96. Liu JR, Fletcher B, Page C, Hu C, Nunez G Baker V. Bcl-xL is

expressed in ovarian carcinoma and modulates chemotherapy-induced

apoptosis. Gynecol Oncol 1998, 70 (3), 398-403.

97. Miyake H. Hanada N, Nakamura H, Kagawa S, Fujiwara T, Hara I, Eto

H, Gohji K, Arakawa S, Kamidono S, Saya H. Overexpression of Bcl-2 in

bladder cancer inhibits apoptosis induced by cisplatin and adenoviral-

mediated p 53 gebe transfer. Oncogene 1998, 16 (7): 1933-43.

98. Minn AJ, Rudin CM, Boise LH, Thompson CB. Expression of bcl-xl

can confer a multidrug resistance phenotype. Blood 1995, 86 (5): 1903-

10.

99.Simonian PL, Grillot AM, Nunez G. Bcl-2 and Bcl-Xl can

differentially block chemotherapy induced cell death. Blood 1997, 90

(3): 1208-16.

100. Jones NA, Turner J, McIlwrath AJ, Brown R, Dive C. Cisplatin-

and paclitaxel-induced apoptosis of ovarian carcinoma cells and the

relationship between bax and bak up-regulation and the functional

status of p 53. Mol Pharmacol 1998, 53 (3): 819-26.

101. Boersma AW, Nooter K, Burger h, Kortland CJ, Stoter G. Bax

upregulation is an early event in cisplatin-induced apoptosis in

human testicular germ-cell tumor cell line NT2, as quantitated by

flow cytometry. Cytometry 1997, 27 (3): 275-82.

102. Lee JU, Hosotani R, Wada H, Doi R, Kosiba T, Fujimoto K,

Miyamoto Y, Mori C, Nakamura N, Shiota K, Imamura M. Mechanism of

apoptosis induced by cisplatin and VP-16 in PANC-1 cells. Anticancer

Res 1997, 17 (5A): 3445-50.

103. Houldsworth J, Xiao H, Murty VV, Chen W, Ray B, Reuter VE, Bosl

GJ, Chaganti RS. Human male germ cell tumor resistance to cisplatin

is linked to TP53 gene mutation. Oncogene 1998, 16 (18): 2345-9.

104. Sakahura C, Sweeney EA, Shirahama T, Igarashi Y, Hakomori S,

Tsujimoto H, Imanishi T, Ogaki M, Yamazaki J, Hagiwara A, Yamaguchi

T, Sawai K, Takahashi T. Overexpression of bax sensitizes breast

cancer MCF-7 cells to cisplatin and etoposide. Surg Today 1997, 27

(7): 676-9.

105. Kondo S, Shinomura Y, Kanayama S, Higashimoto Y, Kiyohara T,

Zushi S, Kitamura S, Ueyama H, Matsuzawa Y. Modulation of apoptosis

by endogenous Bcl-Xl expression in MKN-45 human gastric cancer cells.

Oncogene 1998, 17(20): 2585-91.

106. Nakata B, Muguruma K, Hirakawa K, Chung YS, Yamashita Y, Inoue

T, Matsuoka T, Onoda N, Kato Y, SowaM. Predictive value of Bcl-2 and

Bax protein expression for chemotherapeutic effect in gastric cancer.

Apilot study. Oncol 1998, 55(6): 543-7.

107. Boku N, Chin K, Hosokawa K, Ohtsu A, Tajiri H, Yoshida S, Yamao

T, Kondo H, Shirao K, Shimada Y, Saito D, Hasebe T, Mukai K, Seki S,

Saito H, Johnston PG. Biological markers as a predictor for response

and prognosis of unresectable gastric cancer patients treated with 5-

fluorouracil and cis-platinum. Clin Cancer Res 1998, 4 (6): 1469-74.

108. Herod JJ, Eliopoulos AG, Warwick J, Niedobitek G, Young LS, Kerr

DJ. The prognostic significance of bcl-2 and p 53 expression in

ovarian carcinoma. Cancer Res 1996, 56 (9): 2178-84.

109. Muguruma K, Nakata B, Hirakawa K, Yamashita Y, Onoda N, Inoue T,

Matsuoka T, Kato Y, Sowa. P 53 and Bax protein expression as

predictor of chemotherapeutic effect in gastric carcinoma. Gan To

Kagaku Ryoho 1998, 3: 400-3.

110. Ferguson AW, Flatow U, MacDonald NJ, Larminat F, Bohr VA,

Steeg PS. Increased sensitivity to cisplatin by nm23-transfected

tumor cell lines. Cancer Res 1996; 56: 2931-5.

111.Masumoto N, Nakaano S. Cell signalling and CDDP resistance. Gan

To Kagaku Ryoho 1997, 24(4): 424-30.

112. Demidova NS, Ilynskaya GV, Shiryaeva OA, Chernova OB, Goncharova

SA, Kopnin BP. Decreased sensitivity of multidrug-resistant tumor

cells to cisplatin is correlated with sorcin gene co-amplification.

Neoplasma 1995; 42: 195-201.

Страницы: 1, 2, 3


реферат скачать
НОВОСТИ реферат скачать
реферат скачать
ВХОД реферат скачать
Логин:
Пароль:
регистрация
забыли пароль?

реферат скачать    
реферат скачать
ТЕГИ реферат скачать

Рефераты бесплатно, курсовые, дипломы, научные работы, реферат бесплатно, сочинения, курсовые работы, реферат, доклады, рефераты, рефераты скачать, рефераты на тему и многое другое.


Copyright © 2012 г.
При использовании материалов - ссылка на сайт обязательна.